A. Falcoz

发表

Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab

X. Pivot, B. Degano, D. Vernerey, 2022, Frontiers in Cardiovascular Medicine.

Could 18-FDG PET-CT Radiomic Features Predict the Locoregional Progression-Free Survival in Inoperable or Unresectable Oesophageal Cancer?

C. Borg, L. Boldrini, B. De Bari, 2022, Cancers.

Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review

G. Mouillet, F. Cotté, H. Lemasson, 2021, Quality of Life Research.

Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.

F. Ducray, D. Vernerey, E. Curtit, 2020, Neuro-oncology practice.

Tumor budding is an independent prognostic factor in stage III colon cancer patients: A post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).

J. Emile, F. Ghiringhelli, D. Vernerey, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR).

Y. Bécouarn, J. Emile, F. Bibeau, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The presence of senescent peripheral T-cells is negatively correlated to COVID-19 vaccine-induced immunity in cancer patients under 70 years of age

L. Mansi, Q. Lepiller, A. Bouard, 2023, Frontiers in Immunology.

Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice

X. Pivot, C. Borg, Stefano Kim, 2021, Quality of Life Research.

KONO-S Anastomosis Is Not Superior to Conventional Anastomosis for the Reduction of Postoperative Endoscopic Recurrence in Crohn's Disease.

Z. Lakkis, L. Vuitton, A. Falcoz, 2023, Inflammatory bowel diseases.

A multicenter study evaluating efficacy of immune checkpoint inhibitors in advanced non-colorectal digestive cancers with microsatellite instability.

T. Mazard, Stefano Kim, D. Tougeron, 2024, European journal of cancer.

Survival outcomes in patients with monobloc-resected stage IIC (pT4bN0) colon cancer: A retrospective observational cohort study

A. Falcoz, T. André, Magali Svrcek, 2024, Clinical Colorectal Cancer.

Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.

A. Lièvre, P. Laurent-Puig, C. Lepage, 2023, European journal of cancer.

Prognostic factors for long-term eribulin response in a cohort of patients with HER2-negative metastatic breast cancer

M. Paillard, G. Meynard, L. Mansi, 2024, Clinical Breast Cancer.

Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial.

A. Thiery-Vuillemin, E. Voog, C. Helissey, 2024, European urology oncology.